2025-523368-19-00撤回4 期
A study to investigate the pharmacokinetics and safety of KM04 compared to US-Gonal-f RFF Redi-ject and EU-Gonal-f in healthy adult female volunteers
适应症
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 发起方
- Xentria Inc.
- 入组人数
- 48
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Tom Matthews
Scientific
Xentria Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study to investigate the pharmacokinetics and safety of a single dose of duvakitug in healthy adult participants2025-524617-84-00Sanofi-Aventis Recherche & Developpement50
已完成
1 期
A study to investigate pharmacokinetics and safety of rupatadine (10 mg) and its active metabolites in participants with hepatic impairment compared to matched control participants with normal hepatic functionUrticariaAllergic rhinitis2022-500774-34-00Noucor Health S.A.44
已完成
1 期
Study to evaluate the pharmacokinetics, safety and tolerability of Secukinumab in patients with GCA or PMR2023-507667-19-00Novartis Pharma AG24
招募中
1 期
A study to investigate the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of a CD19/CD20 T-cell engager in participants with B-cell driven ARD.Systemic Lupus Erythematosus2025-522932-15-00Glaxosmithkline Research & Development Limited18
招募中
1 期
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in
Adult Participants with Advanced Solid Tumors Previously Treated with Standard of Care
Therapy2025-521614-26-00AstraZeneca AB13